8 results match your criteria Pediatric Health [Journal]

  • Page 1 of 1

Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years.

Ped Health 2010 Sep;4(4):375-381

Christian Sarkine Autism Treatment Center, James Whitcomb Riley Hospital for Children, IN, USA.

Aripiprazole was recently US FDA-approved to treat irritability in children and adolescents with autistic disorder aged 6-17 years. There are currently only two psychotropics approved by the FDA to treat irritability in the autistic population. This drug profile will discuss available studies of aripiprazole in individuals with pervasive developmental disorders, two of which led to its recent FDA approval. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043611PMC
September 2010
6 Reads

Interventional studies for polycystic ovarian syndrome in children and adolescents.

Ped Health 2010 Feb;4(1):59-73

Children's Hospital at Montefiore, Albert Einstein College of Medicine, 3450 Bainbridge Ave, Bronx, NY 10467, USA, Tel.: +1 718 920 4664, ,

Polycystic ovarian syndrome (PCOS) is characterized by chronic anovulation, clinical and/or biochemical hyperandrogenism, which can be associated with altered insulin action. Symptoms usually begin around menarche, but onset after puberty may also occur as a result of environmental modifiers such as weight gain. The consequences of PCOS extend beyond the reproductive axis; there is a substantial risk for development of metabolic and cardiovascular abnormalities similar to the metabolic syndrome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/phe.09.69DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904463PMC
February 2010
5 Reads

Nonalcoholic fatty liver disease as a comorbidity of childhood obesity.

Ped Health 2009 Jun;3(3):271-281

Department of Pediatrics, University of California, San Diego, California, CA 92103, USA, Tel.: +1 619 543 7544, ,

Childhood obesity is a worldwide health problem associated with an increase in the prevalence and severity of comorbid conditions including nonalcoholic fatty liver disease (NAFLD). The increasing number of children with NAFLD presents a major public health concern. This review focuses on the recent advancements in the understanding of the epidemiology, diagnosis, histology, pathogenesis and treatment of pediatric NAFLD and highlights ongoing challenges and unmet needs in the area. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/phe.09.21DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885801PMC
June 2009
9 Reads

Low levels of 25-hydroxyvitamin D in the pediatric populations: prevalence and clinical outcomes.

Ped Health 2010 Feb;4(1):89-97

Division of Nephrology, Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Ullman 615/Belfer 1008, Bronx, NY 10461, USA, Tel.: +1 718 430 2304, ,

Vitamin D deficiency is becoming increasingly common in the USA. In this review we provide estimates of the prevalence of deficiency, and review the risk factors and the evidence of clinical consequences of vitamin D deficiency. Vitamin D deficiency causes the pediatric disease rickets. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871693PMC
February 2010
5 Reads

Role of β-blocker therapy in pediatric heart failure.

Ped Health 2010 ;4(1):45-58

The Children's Hospital of Philadelphia, Department of Cardiology, 34th & Civic Center Boulevard, Philadelphia, PA 19104, USA Tel.: +1 215 590 3548.

Heart failure is becoming an increasingly common and significant problem in the field of pediatric cardiology. The numerous types of cardiomyopathies, and more recently, long-term survival of patients with congenital heart disease, have added to a growing patient population. Over the last several decades, our knowledge base regarding mechanisms of disease and therapeutic intervention in adult patients with heart failure has drastically changed. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143493PMC
January 2010
11 Reads

Adolescent attitudes towards tanning: does age matter?

Ped Health 2009 Dec;3(6):565-578

Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, USA.

Adolescents seem to be obsessed with tanning. One third of both adolescents and adults report sunbathing. On average, about 20% of adolescents report ever-using of artificial UV tanning devices with 15% currently using them. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/phe.09.55DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374604PMC
December 2009
7 Reads

Emergency treatment options for pediatric traumatic brain injury.

Ped Health 2009 ;3(6):533-541

Department of Critical Care Medicine, & The Safar Center for Resuscitation, Research, University of Pittsburgh, Pittsburgh, PA, USA.

Traumatic brain injury is a leading killer of children and is a major public health problem around the world. Using general principles of neurocritical care, various treatment strategies have been developed to attempt to restore homeostasis to the brain and allow brain healing, including mechanical factors, cerebrospinal fluid diversion, hyperventilation, hyperosmolar therapies, barbiturates and hypothermia. Careful application of these therapies, normally in a step-wise fashion as intracranial injuries evolve, is necessary in order to attain maximal neurological outcome for these children. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828617PMC
January 2009
6 Reads
  • Page 1 of 1